2025-03-10T16:51:42-05:00 2024-06-30 742752212 MASSEY ITSCHNER & CO PC 820 MAIN STREET SUITE 101 KERRVILLE TX 78028 990EZ 2023-07-01 874397344 COALITION OF PET DRUG MANUFACTURERS INC COAL 8303706554 223 GREEN OAKS LOOP FREDERICKSBURG TX 786244576 CHARLES METZGER EXECUTIVE DIRECTOR 8303706554 2025-03-09 1 0 CASEY T MIKESKA P01435690 8302575330 2025-03-07 2023 2025-03-06 01:10:19Z X X WWW.PETDRUGMANUFACTURERS.ORG X X 64500 X 64500 64500 29570 7666 37236 27264 36817 0 64081 36817 64081 36817 64081 0 0 36817 64081 X THE COALITION OF PET DRUG MANUFACTURERS (CPDM) IS A VENUE FOR THE POSITRON EMISSION TOMOGRAPHY (PET) DRUG MANUFACTURING COMMUNITY TO ADVANCE SCIENTIFIC AND REGULATORY PRINCIPLES ASSOCIATED WITH THE MANUFACTURING OF PET DRUGS. THE KEY PURPOSES OF THIS MISSION ARE TO: PROVIDE A MULTI-STAKEHOLDER FORUM TO ADDRESS CURRENT TOPICS WITH GOVERNMENT AGENCIES AND OTHER GROUPS; ESTABLISH SCIENTIFICALLY SOUND AND RATIONAL PRACTICES FOR PET DRUG MANUFACTURING; PROVIDE EDUCATION AND TRAINING; ENABLE THE EXPANSION OF NEW PET DRUGS INTO ROUTINE MANUFACTURING NETWORKS; PROVIDE HIGH-VALUE RESOURCES TO ASSIST PET DRUG MANUFACTURERS WITH GMP COMPLIANCE AND INSPECTION CHALLENGES; ALIGN THE INTERESTS OF THE COMMUNITY OF PET DRUG MANUFACTURERS; AND TO ENGAGE IN ANY AND ALL LAWFUL ACTIVITIES TO ACCOMPLISH THE FOREGOING PRIMARY PURPOSE AND OBJECTIVES, EXCEPT AS RESTRICTED HEREIN. ON NOVEMBER 13-14, 2023, THE COALITION HELD THE 2023 PET DRUGS WORKSHOP WITH THE FDA (AT THE FDA'S SILVER SPRING, MD CAMPUS). OTHER COLLABORATING ORGANIZATIONS INCLUDED THE MEDICAL IMAGING & TECHNOLOGY ALLIANCE (MITA), AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (SNMMI). THIS WAS A MAJOR UNDERTAKING, AND WE ARE WORKING WITH THE FDA TO PUBLISH THE PROCEEDINGS IN THE JOURNAL OF NUCLEAR MEDICINE.ON JANUARY 30, 2024, THE COALITION SUBMITTED COMMENTS REGARDING THE PROPOSED REVISION TO USP CHAPTER 823. THE COALITION'S COMMENTS REGARDING USP <823> WERE DEVELOPED BY A WORKING GROUP OVER THE COURSE OF A FEW MONTHS, SUBMITTED TO CONSTITUENTS FOR THEIR SUGGESTED MODIFICATIONS, AND FINALLY DISCUSSED, MODIFIED AND APPROVED BY THE BOARD. ON FEBRUARY 26, 2024, THE SUBMITTED COMMENTS REGARDING THE FDA'S DRAFT REPORT AND PLAN ON BEST PRACTICE FOR GUIDANCE. THE COMMENTS WERE DEVELOPED BY A WORKING GROUP OVER THE COURSE OF A MONTH AND WERE DISCUSSED, SLIGHTLY MODIFIED AND APPROVED BY THE BOARD.ON APRIL 22, 2024, THE COALITION COMPLETED ITS BYLAWS, WHICH WERE APPROVED BY MEMBERS AT A SUBSEQUENT OPEN BUSINESS MEETING.ON JUNE 10, 2024, THE COALITION HAD AN OPEN BOARD/BUSINESS MEETING AT THE SNMMI 2024 CONFERENCE. IN-PERSON AND VIA ZOOM, THE COALITION INTERACTED WITH UP TO 100 PEOPLE FROM MEMBER ENTITIES AND SOME REPRESENTATIVES FROM THE FDA. 0 0 SUSAN K BUNNING DIRECTOR 1.50 0 0 0 CHRISTOPHER C IGNACE DIRECTOR 1.50 0 0 0 CATHY CUTLER PHD DIRECTOR 1.50 0 0 0 CHARLES METZGER EXECUTIVE DIRECTOR 8.00 0 0 0 SALLY SCHWARZ VICE-CHAIR 2.00 0 0 0 PETER SCOTT DIRECTOR 1.50 0 0 0 HENRY VANBROCKLIN CHAIR 2.00 0 0 0 STEVEN ZIGLER SECRETARY 2.00 0 0 0 X 0 0 0 0 0 0 0 0 METZGER MABRY & ASSOCIATES 223 GREEN OAKS LOOP FREDERICKSBURG TX 78624 8303706554 0 0 0 0 0 0 0 FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES DESCRIPTION: TELEPHONE. AMOUNT: 69. DESCRIPTION: CREDIT CARD & BANK FEES. AMOUNT: 1,376. DESCRIPTION: MEETING/TRAVEL EXPENSE. AMOUNT: 6,221. TOTAL TO FORM 990-EZ, LINE 16: 7,666. THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.